Ultralife Corporation (ULBI)
NASDAQ: ULBI · Real-Time Price · USD
6.15
-0.08 (-1.28%)
At close: Jun 26, 2026, 4:00 PM EDT
6.19
+0.04 (0.65%)
After-hours: Jun 26, 2026, 4:10 PM EDT

Ultralife Statistics

Total Valuation

Ultralife has a market cap or net worth of $103.10 million. The enterprise value is $144.95 million.

Market Cap 103.10M
Enterprise Value 144.95M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date Aug 6, 2026
Ex-Dividend Date n/a

Share Statistics

Ultralife has 16.66 million shares outstanding. The number of shares has decreased by -0.95% in one year.

Current Share Class 16.66M
Shares Outstanding 16.66M
Shares Change (YoY) -0.95%
Shares Change (QoQ) +0.02%
Owned by Insiders (%) 42.26%
Owned by Institutions (%) 32.46%
Float 9.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.55
Forward PS 0.60
PB Ratio 0.80
P/TBV Ratio 1.40
P/FCF Ratio 16.82
P/OCF Ratio 10.44
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.15, with an EV/FCF ratio of 23.64.

EV / Earnings n/a
EV / Sales 0.77
EV / EBITDA 13.15
EV / EBIT 26.07
EV / FCF 23.64

Financial Position

The company has a current ratio of 2.56, with a Debt / Equity ratio of 0.39.

Current Ratio 2.56
Quick Ratio 1.01
Debt / Equity 0.39
Debt / EBITDA 4.08
Debt / FCF 8.27
Interest Coverage 1.47

Financial Efficiency

Return on equity (ROE) is -6.23% and return on invested capital (ROIC) is 3.22%.

Return on Equity (ROE) -6.23%
Return on Assets (ROA) 1.56%
Return on Invested Capital (ROIC) 3.22%
Return on Capital Employed (ROCE) 3.13%
Weighted Average Cost of Capital (WACC) 7.59%
Revenue Per Employee $277,077
Profits Per Employee -$12,115
Employee Count 678
Asset Turnover 0.85
Inventory Turnover 2.75

Taxes

Income Tax -3.21M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.00% in the last 52 weeks. The beta is 0.76, so Ultralife's price volatility has been lower than the market average.

Beta (5Y) 0.76
52-Week Price Change -25.00%
50-Day Moving Average 6.74
200-Day Moving Average 6.42
Relative Strength Index (RSI) 40.55
Average Volume (20 Days) 26,852

Short Selling Information

The latest short interest is 88,589, so 0.53% of the outstanding shares have been sold short.

Short Interest 88,589
Short Previous Month 87,512
Short % of Shares Out 0.53%
Short % of Float 0.93%
Short Ratio (days to cover) 1.28

Income Statement

In the last 12 months, Ultralife had revenue of $187.86 million and -$8.21 million in losses. Loss per share was -$0.49.

Revenue 187.86M
Gross Profit 43.33M
Operating Income 5.56M
Pretax Income -11.51M
Net Income -8.21M
EBITDA 11.03M
EBIT 5.56M
Loss Per Share -$0.49
Full Income Statement

Balance Sheet

The company has $8.89 million in cash and $50.73 million in debt, giving a net cash position of -$41.84 million or -$2.51 per share.

Cash & Cash Equivalents 8.89M
Total Debt 50.73M
Net Cash -41.84M
Net Cash Per Share -$2.51
Equity (Book Value) 129.75M
Book Value Per Share 7.78
Working Capital 67.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $9.88 million and capital expenditures -$3.75 million, giving a free cash flow of $6.13 million.

Operating Cash Flow 9.88M
Capital Expenditures -3.75M
Depreciation & Amortization 5.47M
Net Borrowing -6.13M
Free Cash Flow 6.13M
FCF Per Share $0.37
Full Cash Flow Statement

Margins

Gross margin is 23.06%, with operating and profit margins of 2.96% and -4.37%.

Gross Margin 23.06%
Operating Margin 2.96%
Pretax Margin -6.13%
Profit Margin -4.37%
EBITDA Margin 5.87%
EBIT Margin 2.96%
FCF Margin 3.26%

Dividends & Yields

Ultralife does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.95%
Shareholder Yield 0.95%
Earnings Yield -7.97%
FCF Yield 5.95%

Analyst Forecast

The average price target for Ultralife is $14.00, which is 127.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.00
Price Target Difference 127.64%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Ultralife has an Altman Z-Score of 1.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.75
Piotroski F-Score 4